CPT1A and glioma: Beside the detected remarkable high mTOR activity—which showed intra- and intertumoral heterogeneity with average score 2+ of all mTOR complex expression and activity markers in the studied cases—high expression of CPT1a was detected in all studied human glioma cases compared to normal brain (high scores—3+—were evaluated in 17/18 studied glioma cases Fig. 7).